Hana Douafer

433 total citations
8 papers, 334 citations indexed

About

Hana Douafer is a scholar working on Organic Chemistry, Pulmonary and Respiratory Medicine and Molecular Medicine. According to data from OpenAlex, Hana Douafer has authored 8 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Medicine. Recurrent topics in Hana Douafer's work include Inhalation and Respiratory Drug Delivery (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antimicrobial agents and applications (2 papers). Hana Douafer is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antimicrobial agents and applications (2 papers). Hana Douafer collaborates with scholars based in France, New Zealand and United States. Hana Douafer's co-authors include Jean Michel Brunel, Véronique Andrieu, Otto Phanstiel, Aliasghar Jarrahpour, Saghi Sepehri, Edward Turos, Melissa M. Cadelis, Marie‐Lise Bourguet‐Kondracki, Ahmad Gholami and Roghayeh Heiran and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Hana Douafer

8 papers receiving 330 citations

Peers

Hana Douafer
Hana Douafer
Citations per year, relative to Hana Douafer Hana Douafer (= 1×) peers Mareike Klinger-Strobel

Countries citing papers authored by Hana Douafer

Since Specialization
Citations

This map shows the geographic impact of Hana Douafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Douafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Douafer more than expected).

Fields of papers citing papers by Hana Douafer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Douafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Douafer. The network helps show where Hana Douafer may publish in the future.

Co-authorship network of co-authors of Hana Douafer

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Douafer. A scholar is included among the top collaborators of Hana Douafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Douafer. Hana Douafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cadelis, Melissa M., Rebecca C. Deed, Hana Douafer, et al.. (2022). Valorisation of the diterpene podocarpic acid – Antibiotic and antibiotic enhancing activities of polyamine conjugates. Bioorganic & Medicinal Chemistry. 64. 116762–116762. 5 indexed citations
2.
Douafer, Hana, Véronique Andrieu, Emmanuel Wafo, Michelle Sergent, & Jean Michel Brunel. (2021). Feasibility of an inhaled antibiotic/adjuvant dry powder combination using an experimental design approach. International Journal of Pharmaceutics. 599. 120414–120414. 2 indexed citations
3.
Douafer, Hana, Véronique Andrieu, & Jean Michel Brunel. (2020). Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. Journal of Controlled Release. 325. 276–292. 54 indexed citations
4.
Douafer, Hana, Véronique Andrieu, Emmanuel Wafo, & Jean Michel Brunel. (2020). Characterization of a new aerosol antibiotic/adjuvant combination for the treatment of P. aeruginosa lung infections. International Journal of Pharmaceutics. 586. 119548–119548. 9 indexed citations
5.
Heiran, Roghayeh, Saghi Sepehri, Aliasghar Jarrahpour, et al.. (2020). Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives. Bioorganic Chemistry. 102. 104091–104091. 35 indexed citations
6.
Cadelis, Melissa M., Marie‐Lise Bourguet‐Kondracki, Marine Blanchet, et al.. (2020). Spermine Derivatives of Indole‐3‐carboxylic Acid, Indole‐3‐acetic Acid and Indole‐3‐acrylic Acid as Gram‐Negative Antibiotic Adjuvants. ChemMedChem. 16(3). 513–523. 21 indexed citations
7.
Douafer, Hana, et al.. (2020). Antibiotic Adjuvants to Rescue Pseudomonas aeruginosa from Tetracycline Antibiotics Resistance. Anti-Infective Agents. 19(1). 110–116. 3 indexed citations
8.
Douafer, Hana, Véronique Andrieu, Otto Phanstiel, & Jean Michel Brunel. (2019). Antibiotic Adjuvants: Make Antibiotics Great Again!. Journal of Medicinal Chemistry. 62(19). 8665–8681. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026